Loeb Partners’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
Other funds holding RIGL
TA
Loeb Partners's RIGL Position: Q2 2019 in Review
Loeb Partners sold out of Rigel Pharmaceuticals (RIGL) in Q2 2019, closing a stake of 200 shares — an estimated $5K sold.
Loeb Partners first reported a position in RIGL in Q4 2018 and held it in 2 quarters. The position peaked at $5K in Q1 2019. 127 funds tracked by Wall St. Rank hold RIGL as of Q2 2019.
- Loeb Partners reported no remaining Rigel Pharmaceuticals position as of Q2 2019 after selling out during the quarter.
- Loeb Partners sold 200 Rigel Pharmaceuticals shares in Q2 2019, an estimated $5K.
- Loeb Partners first reported a position in Rigel Pharmaceuticals in Q4 2018 and held it in 2 quarters.
- Loeb Partners's Rigel Pharmaceuticals position peaked at $5K in Q1 2019.
- 127 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q2 2019.
Based on Loeb Partners's 13F filing for Q2 2019.